Potential role of Yashtimadhu Pratisarana Karma in supportive care of tobacco induced buccal mucosa carcinoma: A review
Ayush Journal of Integrative Oncology · 2026
DOI: 10.4103/ajio.ajio_17_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ayush Journal of Integrative Oncology, 2026. Verfasst von Vibha Kulhari und 3 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Buccal mucosa carcinoma is a common and aggressive subtype of oral squamous cell carcinoma, predominantly associated with chronic tobacco chewing. Continuous exposure to tobacco leads to persistent mucosal inflammation, oxidative stress, epithelial dysplasia, and malignant transformation. Conventional management approaches, including surgery, radiotherapy, and chemotherapy, remain the mainstay of treatment; however, these modalities are frequently accompanied by significant local adverse effects such as oral mucositis, pain, delayed wound healing, secondary infections, and impaired oral function, adversely affecting patient’s quality of life. This necessitates the exploration of safe and effective supportive care strategies. Yashtimadhu ( Glycyrrhiza glabra Linn.) is a well-documented medicinal plant in Ayurveda, traditionally indicated for Mukharoga and Vrana due to its Shothahara , Vedanasthapana , Vranaropana , and Rasayana properties. Pratisaraṇa Karma , a localized therapeutic procedure involving gentle application of medicated substances over the affected mucosa, is specifically advocated for oral lesions and inflammatory conditions. Modern pharmacological studies have identified bioactive constituents of Yashtimadhu , such as glycyrrhizin, glycyrrhetinic acid, liquiritigenin, and licochalcones, which exhibit anti-inflammatory, antioxidant, antimicrobial, immunomodulatory, and epithelial regenerative activities. These effects are mediated through inhibition of pro-inflammatory cytokines, suppression of nuclear factor-kappa B signaling, reduction of oxidative stress, and enhancement of mucosal healing. In tobacco-induced buccal mucosa carcinoma, Yashtimadhu Pratisaraṇa Karma may play a valuable supportive role by reducing treatment-related oral toxicities, promoting wound healing, reducing pain and inflammation, and improving oral comfort. This review integrates classical Ayurvedic principles with contemporary biomedical evidence to highlight its therapeutic relevance, emphasizing the need for further preclinical and clinical studies to validate efficacy and standardize treatment protocols.
Zitieren
APA
Kulhari, V., Bhanupriya, R., Thakur, A., & Rajagopala, M. (2026). Potential role of Yashtimadhu Pratisarana Karma in supportive care of tobacco induced buccal mucosa carcinoma: A review. Ayush Journal of Integrative Oncology. https://doi.org/10.4103/ajio.ajio_17_26
Vancouver
Kulhari V, Bhanupriya R, Thakur A, Rajagopala M. Potential role of Yashtimadhu Pratisarana Karma in supportive care of tobacco induced buccal mucosa carcinoma: A review. Ayush Journal of Integrative Oncology. 2026. doi:10.4103/ajio.ajio_17_26
BibTeX
@article{Kulhari2026,
author = {Kulhari, Vibha and Bhanupriya, R. and Thakur, Akanksha and Rajagopala, Manjusha},
title = {Potential role of Yashtimadhu Pratisarana Karma in supportive care of tobacco induced buccal mucosa carcinoma: A review},
journal = {Ayush Journal of Integrative Oncology},
year = {2026},
doi = {10.4103/ajio.ajio_17_26}
}
EUVIMED